1 Min Read
June 19 (Reuters) -
* Melinta Therapeutics announces U.S. FDA approval of baxdela™ (delafloxacin) for acute bacterial skin and skin structure infections (absssi) Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.